1 Buyon JP, Kim MY, Guerra MM, et al. Predictors of pregnancy outcomes in patients with lupus: A cohort study. Ann Intern Med 2015;163:153–63. doi:10.7326/M14-2235
2 Kim MY, Guerra MM, Kaplowitz E, et al. Complement Activation Predicts Adverse Pregnancy Outcome in Patients with Systemic Lupus Erythematosus and/or AntiPhospholipid Antibodies. Ann Rheum Dis 2018;77:549–55. doi:10.1136/annrheumdis-2017-212224.Complement
3 Jill P. Buyon1, Peter M. Izmirly2, H. Michael Belmont3, John Conklin4, Nicole Kaiden5, Jane E. Salmon6, Roberta Alexander4 and Thierry Dervieux4, 1Medicine, New York University School of Medicine, New York, NY, 2NYU Langone Health, New York, NY, 3Medicine N. Erythrocyte Bound C4d in the Presence of Adverse Pregnancy Outcome Events in Pregnant Women with Systemic Lupus Erythematosus. ACR2018 2018.
4 Zeisler H, Llurba E, Chantraine F, et al. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med 2016;374:13–22. doi:10.1056/nejmoa1414838
5 Kim MY. Angiogenic Factor Imbalance Early in Pregnancy Predicts Adverse Outcomes in Patients with Lupus and Antiphospholipid Antibodies: Results of the PROMISSE Study. Am J Obs Gynecol 2016;214:1–23. doi:10.1016/j.ajog.2015.09.066.Angiogenic
6 Guilherme De Jesus1, Marcela Lacerda 1, Bruna Rodrigues 1, Flavia dos Santos 1, Adriana Nascimento 1, Luis Cristóvão Porto 1, Nilson Ramires de Jesús 1, Roger Levy 2 and Evandro Klumb 1, 1Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, 2 P. sFlt-1, PlGF and VEGF in the Differential Diagnosis Between Active SLE Nephritis During Pregnancy and Preeclampsia. ACR 2019.
7 Mosimann B, Amylidi-Mohr SK, Surbek D, et al. First Trimester Screening for Preeclampsia–a Systematic Review. Hypertens Pregnancy 2020;39:1–11. doi:10.1080/10641955.2019.1682009
8 Rolnik DL, Wright D, Poon LC, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med 2017;377:613–22. doi:10.1056/nejmoa1704559
9 Sammaritano LR, Bermas BL, Chakravarty EE, et al. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol 2020;72:529–56. doi:10.1002/art.41191
10 Kan N, Silverman ED, Kingdom J, et al. Serial echocardiography for immune-mediated heart disease in the fetus: results of a risk-based prospective surveillance strategy. Prenat Diagn 2017;37:375–82. doi:10.1002/pd.5021
11 宮野 章ら. 酵素免疫測定法による抗 SS-A/B抗体標準化の検討.
12 Izmirly P, Kim M, Friedman DM, et al. Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers. J Am Coll Cardiol 2020;76:292–302. doi:10.1016/j.jacc.2020.05.045
13 Ramos-Casals M, Brito-Zerón P, Bombardieri S, et al. EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies. Ann Rheum Dis 2020;79:3–18. doi:10.1136/annrheumdis-2019-216114
14 Cuneo BF, Sonesson SE, Levasseur S, et al. Home Monitoring for Fetal Heart Rhythm During Anti-Ro Pregnancies. J Am Coll Cardiol 2018;72:1940–51. doi:10.1016/j.jacc.2018.07.076
15 Cuneo BF, Ambrose SE, Tworetzky W. Detection and successful treatment of emergent anti-SSA–mediated fetal atrioventricular block. Am J Obstet Gynecol 2016;215:527–8. doi:10.1016/j.ajog.2016.07.002
16 Eliasson H, Sonesson SE, Sharland G, et al. Isolated atrioventricular block in the fetus: A retrospective, multinational, multicenter study of 175 patients. Circulation 2011;124:1919–26. doi:10.1161/CIRCULATIONAHA.111.041970
17 Couture J, Bernatsky S, Scott S, et al. Brief Report: Risk of Childhood Rheumatic and Nonrheumatic Autoimmune Diseases in Children Born to Women With Systemic Lupus Erythematosus. Arthritis Rheumatol 2018;70:1796–800. doi:10.1002/art.40570
18 Couture J, Ben-Shoshan M, Pineau CA, et al. Risk of Allergic Conditions in Children Born to Women With Systemic Lupus Erythematosus. Arthritis Care Res 2018;70:315–9. doi:10.1002/acr.23251
19 Marios Rossides, MD, MSc, Cathina Nguyen, MPH, Elizabeth V. Arkema, ScD, and Julia F. Simard S. Asthma in children of mothers with systemic lupus erythematosus and the role of preterm birth. Arthritis Care Res 2018;70:1269–74. doi:10.1002/acr.23472.Asthma
20 Rom AL, Wu C Sen, Olsen J, et al. Parental rheumatoid arthritis and long-term child morbidity: A nationwide cohort study. Ann Rheum Dis 2015;75:1831–7. doi:10.1136/annrheumdis-2015-208072
21 Marder W, Romero VC, Ganser MA, et al. Increased usage of special educational services by children born to mothers with systemic lupus erythematosus and antiphospholipid antibodies. Lupus Sci Med 2014;1:12–7. doi:10.1136/lupus-2014-000034
22 Vinet É, Pineau CA, Clarke AE, et al. Increased risk of autism spectrum disorders in children born to women with systemic lupus erythematosus: Results from a large population-based cohort. Arthritis Rheumatol 2015;67:3201–8. doi:10.1002/art.39320
23 Andreoli L, Nalli C, Lazzaroni MG, et al. Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals. Clin Rev Allergy Immunol Published Online First: 2021. doi:10.1007/s12016-021-08857-2
24 Nalli C, Iodice A, Andreoli L, et al. Long-term neurodevelopmental outcome of children born to prospectively followed pregnancies of women with systemic lupus erythematosus and/or antiphospholipid syndrome. Lupus 2017;26:552–8. doi:10.1177/0961203317694960
25 D. WARE BRANCH. Outcome of treated pregnancies in women with antiphospholipid syndrome.pdf. 1992;:614ー620.
26 Bouvier S, Cochery-Nouvellon É, Lavigne-Lissalde G, et al. Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study. Blood 2014;123:404–13. doi:10.1182/blood-2013-08-522623
27 Bramham K, Thomas M, Nelson-Piercy C, et al. First-trimester low-dose prednisolone in refractory antiphospholipid antibody - related pregnancy loss. Blood 2011;117:6948–51. doi:10.1182/blood-2011-02-339234
28 Tenti S, Cheleschi S, Guidelli GM, et al. Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature. Autoimmun Rev 2016;15:226–35. doi:10.1016/j.autrev.2015.11.009
29 Sciascia S, Hunt BJ, Talavera-Garcia E, et al. The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies. Am J Obstet Gynecol 2016;214:273.e1-273.e8. doi:10.1016/j.ajog.2015.09.078
30 Vahedian-Azimi A, Karimi L, Reiner Ž, et al. Effects of statins on preeclampsia: A systematic review. Pregnancy Hypertens 2021;23:123–30. doi:10.1016/j.preghy.2020.11.014 |